SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001264124-12-000013
Filing Date
2012-01-12
Accepted
2012-01-12 16:35:57
Documents
1
Period of Report
2012-01-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4007
  Complete submission text file 0001264124-12-000013.txt   5387
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5301 STEVENS CREEK BLVD MS 1A-LC SANTA CLARA CA 95051
Business Address
CLARK PAUL N (Reporting) CIK: 0001222248 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 12524529